Skip to main content
. 2022 Nov 8;17(11):e0276904. doi: 10.1371/journal.pone.0276904

Fig 1. Clinical characteristics of peripheral blood during HCC tumorigenesis.

Fig 1

A, B. Changes in peripheral blood AFP and hemoglobin levels in a cohort of patients with LC, HCC, and HC during HCC tumorigenesis. AFP was clinically detected by electrochemiluminescence immunoassays. Hemoglobin was clinically detected by the cyanmethemoglobin method. C–E. Changes in the number of peripheral blood RBCs, platelets, and leukocytes in a cohort of patients with LC, HCC, and HC. Blood cells were clinically detected using a fully automatic hematology analyzer. Statistical results were analyzed using the Wilcoxon rank-sum test. ***, P < 0.001; **, P < 0.01, *, P < 0.05.